Study of Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose is to evaluate the ease of use and technical challenges encountered during
subcutaneous infusion of Lactated Ringer's (LR) solution, preceded by recombinant human
hyaluronidase (hylenex), utilizing commonly used angiocatheter gauges and button delivery
systems. The safety and tolerability of hylenex-augmented SC infusion of LR through these
delivery systems is also being evaluated.